A study for a 54 year old woman who takes Lipitor, Xeljanz Xr - from FDA reports


Summary

123 females aged 54 (±5) who take the same drugs are studied. This is a personalized study for a 54 year old female patient who has High Cholesterol, Rheumatoid Arthritis. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 14, 2017

123 females aged 54 (±5) who take Lipitor, Xeljanz Xr are studied.


Number of reports submitted per year:

Lipitor, Xeljanz Xr for a 54-year old woman.

Information of the patient in this study:

  • Age: 54
  • Gender: female
  • Conditions: High Cholesterol, Rheumatoid Arthritis
  • Drugs taken:
    • Lipitor (atorvastatin calcium)
    • Xeljanz Xr (tofacitinib citrate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Ileal Haemorrhage: 0 (0% of females aged 54 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • headache
  • hypersensitivity
  • insomnia
  • fatigue
  • hypoaesthesia
  • chest pain
  • inflammation
  • sleep walking
  • sinusitis - chronic
  • sjogren syndrome
1 - 6 months:
  • headache
  • fatigue
  • drug ineffective
  • nasopharyngitis
  • upper respiratory tract infection
  • ear infection staphylococcal
  • drooling
  • eye swelling
  • otitis
  • musculoskeletal pain
6 - 12 months:
  • drug ineffective
  • cardiomyopathy
  • cardiac failure
  • joint pain
  • fatigue
  • rashes
  • neuropathy peripheral
  • pain in extremity
  • hyperhidrosis
  • haemorrhage
1 - 2 years:
  • fatigue
  • otitis media acute
  • chest pain
  • activities of daily living impaired
  • costochondritis
2 - 5 years:
  • herpes zoster
  • drug ineffective
5 - 10 years:
  • haemorrhagic stroke
  • pneumonia cryptococcal
  • disseminated tuberculosis
10+ years:
n/a
not specified:
  • fatigue
  • drug ineffective
  • upper respiratory tract infection
  • peripheral swelling
  • headache
  • pain in extremity
  • muscle spasms
  • joint pain
  • nausea
  • bronchitis

Top conditions involved for these people *:

  • Pain (11 people, 8.94%)
  • Hypothyroidism (6 people, 4.88%)
  • Diabetes (5 people, 4.07%)
  • Arthritis (5 people, 4.07%)
  • Thyroid Diseases (4 people, 3.25%)

Top co-used drugs for these people *:

  • Methotrexate (20 people, 16.26%)
  • Metformin (19 people, 15.45%)
  • Synthroid (17 people, 13.82%)
  • Enbrel (17 people, 13.82%)
  • Plaquenil (15 people, 12.20%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Lipitor, Xeljanz xr, High cholesterol, Ileal haemorrhage, Rheumatoid arthritis

You may be interested in these reviews

More reviews for: Lipitor, Xeljanz xr, High cholesterol, Ileal haemorrhage, Rheumatoid arthritis